ArticleEuropean journal of haematology2019

Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.

Tomoki Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.